Amlitelimab SC: Data from P3 COAST-1 trial (NCT06130566) for atopic dermatitis in 2026 (Sanofi) - Jan 30, 2025 - Q4 & FY 2024 Results: Data from P3 COAST-2 trial (NCT06181435) for atopic dermatitis in 2026
P3 data • Atopic Dermatitis • Dermatology • Immunology
|